Ranexa and Dapsone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranexa (ranolazine) and Dapsone (dapsone). Common drug interactions include osteoporosis among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Ranexa and Dapsone. It is created by eHealthMe based on reports of 10 people who take the same drugs from the FDA, and is updated regularly.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.



On Jul, 22, 2026

10 people who take Ranexa and Dapsone together, and have interactions are studied.

Ranexa and Dapsone drug interactions.

What are the common drug interactions of Ranexa and Dapsone, by gender? *:

female:

  1. Osteoporosis (bones weak and more likely to break)
  2. Pain
  3. Ankle fracture
  4. Cardiac failure
  5. Dyspnoea (difficult or laboured respiration)
  6. Leprosy (a disfiguring disease caused by the mycobacterium leprae bacteria)
  7. Blood glucose increased
  8. Blood sodium decreased
  9. Vomiting
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

male:

  1. Cardiac arrest
  2. Adverse drug reaction
  3. Herpes zoster
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Ranexa and Dapsone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cardiac arrest
  2. Adverse drug reaction
  3. Blood glucose increased
  4. Blood sodium decreased
  5. Herpes zoster
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Vomiting

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 30.00%
  2. Hiv Infection: 3 people, 30.00%
  3. Type 2 Lepra Reaction: 1 person, 10.00%
  4. Stress And Anxiety: 1 person, 10.00%
  5. Pain: 1 person, 10.00%
  6. Osteoporosis (bones weak and more likely to break): 1 person, 10.00%
  7. Neuropathy Peripheral (surface nerve damage): 1 person, 10.00%
  8. Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 10.00%
  9. Multiple Myeloma (cancer of the plasma cells): 1 person, 10.00%
  10. Leprosy (a disfiguring disease caused by the mycobacterium leprae bacteria): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ranexa and Dapsone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranexa and Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dapsone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ranolazine and dapsone (the active ingredients of Ranexa and Dapsone, respectively), and Ranexa and Dapsone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: